Why warfarin and heparin need to overlap when treating acute venous thromboembolism

Disease-a-Month

Volumn 51, Issue 2-3, 2005, Pages 112-115

  Wittkowsky, Ann K ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTIVITAMIN K; COUMARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ACUTE DISEASE; ANTICOAGULATION; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; HYPERCOAGULABILITY; INJECTION; INTERNATIONAL NORMALIZED RATIO; NONHUMAN; PATHOPHYSIOLOGY; PATIENT; PRACTICE GUIDELINE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SYMPTOM; THROMBOPLASTIN TIME; VENOUS THROMBOEMBOLISM;

EID: 19344362913     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2005.03.005     Document Type: Article

References (12)

1. J. Hirsh, G. Guyatt, G.W. Albers The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy evidence-based guidelines Chest 126 suppl 3 2004 172 174
2. H.R. Buller, G. Agnelli, R.D. Hull Antithrombotic therapy for venous thromboembolic disease. The Seventh ACP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 3 2004 401 428
3. E.G. Bovill, K.G. Mann Warfarin and the biochemistry of vitamin K dependent proteins Adv Exp Med Biol 214 1987 17 46
4. J.G. Kelly, K. O'Malley Clinical pharmacokinetics of oral anticoagulants Clin Pharmacokinet 4 1979 1 15
5. M.E. Winter Basic Clinical Pharmacokinetics ed 4. 2003 Lippincott, Williams and Wilkins Philadelphia, PA
6. Y. Stirling Warfarin-induced changes in procoagulant and anticoagulant proteins Blood Coag Fibrinolysis 6 1995 361 373
7. P. Weiss, G.A. Soff, H. Halkin Decline of proteins C and S, and factors II, VII, IX and X during the initiation of warfarin therapy Thromb Res 45 1987 783 790
8. S. Wessler, S.N. Gitel Warfarin from bedside to bench New Engl J Med 311 1984 645 652
9. A. Zivelin, L.V.M. Roa, S.I. Rapaport Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors J Clin Invest 92 1993 2131 2140
10. F.A. Nizzi, H.S. Kaplan Protein C and S deficiency Semin Thromb Haemost 25 1999 265 272
11. L. Harrison, M. Johnston, M.P. Massicotte Comparison of 5 mg and 10 mg loading doses in initiation of warfarin therapy Ann Intern Med 126 1997 133 136
12. D.P.M. Brandjes, H. Heijboer, H.R. Buller Acenocoumarol and heparin compared to acenocoumarol alone in the initial treatment of proximal vein thrombosis New Engl J Med 327 1992 1485 1489